DePuy Attune Knee Lawsuits in 2026: Premature Failure Claims and Who Qualifies

The DePuy Attune knee system has faced lawsuits alleging that its tibial component can loosen years ahead of schedule, forcing patients into painful revision surgery. The first U.S. suits were filed in 2017, and claims continue in 2026. This guide covers the alleged defect, the litigation status, and who may qualify to file.

For a visual walkthrough of money and debt topics, you can also follow the Problem Solved channel.

Key facts

  • The Attune system received FDA 510(k) clearance in December 2010 based on claimed substantial similarity to DePuy's earlier P.F.C. SIGMA knee, not on full clinical trials.
  • The core allegation is debonding of the tibial baseplate at the implant-cement interface: the smooth tibial surface allegedly prevents proper bonding with bone cement, causing early loosening.
  • Nine orthopedic surgeons reported an unusually high rate of premature Attune failures in the Journal of Knee Surgery — pain on weight bearing, effusion, and decreased range of motion, some within two years of surgery.
  • The first U.S. lawsuits were filed in September 2017 in Alabama, with filings spreading nationwide afterward; DePuy has since redesigned the system as the Attune S+.
  • As of October 2026, there is no active federal multidistrict litigation for knee replacements — Attune cases proceed as individual lawsuits, not as a consolidated MDL.

The alleged defect, in plain terms

A total knee replacement works only if every component stays fixed. In the Attune lawsuits, plaintiffs allege the tibial baseplate — the metal plate anchoring the implant to the shinbone — fails to bond securely with the bone cement, then gradually loosens inside the joint. Once debonding starts, patients report the classic pattern: pain when bearing weight, swelling, a knee that feels unstable, and declining range of motion. Because a successful knee replacement should last roughly twenty years, failure within the first few years is the fact pattern these claims are built on.

How the litigation unfolded

Trouble became public when surgeons published peer-reviewed observations of early Attune failures, attributing them to debonding at the cement interface. The first patient lawsuits arrived in 2017, including the Mississippi case Joyce Rogers v. DePuy Synthes Sales, Inc., and accused DePuy of knowing about elevated revision rates without adequately warning surgeons and patients. DePuy countered with registry data from the United Kingdom and Australia showing about 99% survivorship at four years. In 2026 the cases remain individual state-court filings; unlike the Zimmer NexGen knee litigation of the 2010s, no federal MDL currently exists for Attune claims.

Who qualifies to file an Attune claim

You may qualify if you received a DePuy Attune knee implant and experienced premature failure: persistent pain or instability, a diagnosis of tibial loosening or debonding on imaging, and — most powerfully — a revision surgery that replaced the failed component. Claims are strongest when the failure occurred within a few years of the original implantation, matching the published failure pattern, and when surgical notes document loosening at the implant-cement interface. You will need to confirm which implant model you actually received; your surgical records and the implant sticker in your operative report identify it. A medical device lawyer can match your records against the litigation criteria before anything is filed.

What a successful claim must establish

These are product-liability claims, so they follow a different logic from medical malpractice. You generally must show the defect existed when the device left the manufacturer's control and that the defect directly caused your injury. The three standard theories are design defect (the tibial surface was unreasonably prone to debonding), manufacturing defect (your implant departed from its intended specifications), and failure to warn (DePuy knew of elevated failure risk and did not tell surgeons or patients). Revision-surgery records, intraoperative findings of loosening, and expert testimony from orthopedic surgeons connect the implant to the injury. Compensation in these cases varies widely by case, and most settlements are confidential, so no honest source can quote you a typical payout.

The Attune S+ redesign and what it means for you

DePuy has replaced the original Attune design with the Attune S+, which plaintiffs' lawyers describe as an internal fix developed while the debonding allegations were known. The redesign matters to your claim in two ways: it helps establish the timeline of what DePuy knew and when, and it confirms that your implant is one of the original-design components at issue. If you received an Attune knee but have no symptoms, the redesign is simply information — routine follow-up with your orthopedic surgeon is the right move, not litigation.

Mistakes that weaken Attune claims

The costliest error is discarding evidence: keep your operative reports, implant identification stickers, imaging, and every record from both the original surgery and any revision. The second is confusing surgeon error with device failure — operating on a failed implant does not automatically make your surgeon a defendant, and naming the wrong party wastes your filing window. The third is assuming an MDL will gather your case automatically; with no active federal knee-replacement MDL, your claim must be filed individually and on time. Claims over other manufacturers' implants, such as the Exactech implant litigation, follow a similar evidence pattern.

Who Benefits From This — and Who Does Not

Who benefits most from this guide:

Attune recipients with premature failure. How: persistent pain or instability, a diagnosis of tibial loosening or debonding on imaging, and — most powerfully — a revision surgery that replaced the failed component. The core allegation is debonding of the tibial baseplate at the implant-cement interface, so your records must connect your symptoms to that mechanism.

Claimants who kept their evidence. How: keep your operative reports, implant identification stickers, imaging, and every record from both the original surgery and any revision. Product-liability claims must show the defect existed when the device left the manufacturer's control and directly caused your injury — and medical-device cases like the Tepezza hearing-loss lawsuits show how documentation decides these fights.

People who can separate device failure from surgeon error. How: operating on a failing knee is not the same as a defective knee. Confusing the two weakens the claim — the three standard product-liability theories all run against the manufacturer, not the surgeon.

Who does not benefit:

People whose Attune knee is functioning normally — there is no claim without failure. Patients whose problems clearly stem from surgical error rather than the device. And anyone who discarded every surgical record: without proof of which implant you received, the case cannot get off the ground.

General information only — not legal advice. Mass tort litigation and deadlines are jurisdiction-specific; consult a licensed attorney.

Frequently asked questions

Was the DePuy Attune knee recalled?

The FDA has issued at least one Class II recall related to Attune labeling. The lawsuits, however, go beyond labeling: they allege the tibial design itself is defective and prone to debonding, which is a broader claim than any single recall.

How soon after surgery did the alleged failures occur?

The published surgical reports describe pain on weight bearing, effusion, and decreased range of motion within about two years of implantation, with intraoperative findings of gross loosening at the implant-cement interface. Failures matching this early timeline form the core of the litigation.

Is there a class action or MDL I can join for Attune?

As of October 2026, there is no active federal multidistrict litigation for knee replacements, including Attune claims. Cases proceed as individual lawsuits, so you need your own filing within your state's deadline.

What records do I need to prove which implant I received?

Your operative report from the original knee replacement, the implant identification sticker (usually pasted into the hospital record), and any revision-surgery notes. Your surgeon's office or the hospital's medical-records department can provide these on request.

Who should talk to a mass tort attorney about Attune?

Anyone who received a DePuy Attune knee implant and suffered premature failure: persistent pain or instability, a diagnosis of tibial loosening or debonding on imaging, and especially a revision surgery that replaced the failed component — with operative reports and implant identification records intact.

Who is unlikely to have a viable Attune claim?

People whose Attune knee is functioning normally, since there is no claim without failure. Patients whose problems stem from surgical error rather than the device, because these are product-liability claims against the manufacturer. And anyone who discarded every surgical record — without proof of which implant was used, the case cannot proceed.

This article is general information about medical-device litigation, not legal or medical advice. Consult a qualified attorney and your own surgeon about your specific situation before taking any legal or medical step.

Watch on YouTube

Problem Solved on YouTube